Latest posts by Anurav Dhwaj (see all)
- Bhoomi is a Disaster, Sanjay Dutt Deserved a Better Comeback. - 02/10/2017
- Amazon SHOP CASHLESS CONTEST 4th – 5th September 2017 - 04/09/2017
- Beauty Bounty 30% Off on Amazon India On APP - 27/12/2016
Abdul Bashit, an 11-year-old boy from Pakistan and the eldest of three siblings, developed severe jaundice soon after birth. He was diagnosed with the Crigler-Najjar syndrome — a condition seen in 1 in a million babies that causes a toxic form of the bilirubin pigment to rise in the blood.
To prevent complications like brain damage and hearing loss from this condition, Abdul underwent continuous phototherapy (a common treatment for reducing high bilirubin levels) during the first two months of his life. Thereafter, he was discharged with phototherapy continuing at home.
As he grew older, his skin thickened and light penetration decreased, making the therapy less effective. His would miss school to remain under the lights as long as possible and stay under the phototherapy unit all night, bearing the intense light and heat for survival. The persistent yellow colour of his eyes and skin would bother him. Since the only permanent treatment was a liver transplant, he was referred to Indraprastha Apollo Hospitals in Delhi, where he underwent a successful procedure in October.
According to Dr. Anupam Sibal, group medical director (Apollo Hospitals) and senior consultant (paediatric gastroenterologist and hepatologist, Indraprastha Apollo Hospitals) said: “The child is doing well. The family expressed a desire to meet Salman Khan and we are delighted that Abdul could meet his hero in Mumbai yesterday.”